Alcon's "Pazeo" Receives FDA Approval

Once a day ocular antihitsamine (anti-itch): http://formularyjournal.modernmedicine.com/formulary-journal/news/fda-approves-drug-ocular-allergy-itch-relief "FDA has approved olopatadine hydrochloride ophthalmic solution (Pazeo, Alcon, a division of Novartis) 0.7% for the treatment of ocular itch relief related to eye allergies. Pazeo is a 1-drop daily ocular itch relief product for allergic conjunctivitis." Olopatadine is the same drug as the old "Patanol" and "Pataday", except in a more concentrated form (0.7% for Pazeo vs 0.1% and 0.2% for Patanol and Pataday, respectively). The itch relief is supposed to last longer with the increased concentration.